443 related articles for article (PubMed ID: 35200463)
1. Drug Delivery Challenges and Current Progress in Nanocarrier-Based Ocular Therapeutic System.
Akhter MH; Ahmad I; Alshahrani MY; Al-Harbi AI; Khalilullah H; Afzal O; Altamimi ASA; Najib Ullah SNM; Ojha A; Karim S
Gels; 2022 Jan; 8(2):. PubMed ID: 35200463
[TBL] [Abstract][Full Text] [Related]
2. Fostering the unleashing potential of nanocarriers-mediated delivery of ocular therapeutics.
Datta D; Priyanka Bandi S; Colaco V; Dhas N; Siva Reddy DV; Vora LK
Int J Pharm; 2024 Jun; 658():124192. PubMed ID: 38703931
[TBL] [Abstract][Full Text] [Related]
3. Mechanistic modeling of ophthalmic drug delivery to the anterior chamber by eye drops and contact lenses.
Gause S; Hsu KH; Shafor C; Dixon P; Powell KC; Chauhan A
Adv Colloid Interface Sci; 2016 Jul; 233():139-154. PubMed ID: 26318359
[TBL] [Abstract][Full Text] [Related]
4. Nanocarriers for ocular drug delivery: current status and translational opportunity.
Gorantla S; Rapalli VK; Waghule T; Singh PP; Dubey SK; Saha RN; Singhvi G
RSC Adv; 2020 Jul; 10(46):27835-27855. PubMed ID: 35516960
[TBL] [Abstract][Full Text] [Related]
5. Ocular drug delivery.
Gaudana R; Ananthula HK; Parenky A; Mitra AK
AAPS J; 2010 Sep; 12(3):348-60. PubMed ID: 20437123
[TBL] [Abstract][Full Text] [Related]
6. Ocular drug delivery systems: An overview.
Patel A; Cholkar K; Agrahari V; Mitra AK
World J Pharmacol; 2013; 2(2):47-64. PubMed ID: 25590022
[TBL] [Abstract][Full Text] [Related]
7. Promising therapeutic drug delivery systems for glaucoma: a comprehensive review.
Singh RB; Ichhpujani P; Thakur S; Jindal S
Ther Adv Ophthalmol; 2020; 12():2515841420905740. PubMed ID: 32206746
[TBL] [Abstract][Full Text] [Related]
8. Nanotechnology based drug delivery systems for the treatment of anterior segment eye diseases.
Onugwu AL; Nwagwu CS; Onugwu OS; Echezona AC; Agbo CP; Ihim SA; Emeh P; Nnamani PO; Attama AA; Khutoryanskiy VV
J Control Release; 2023 Feb; 354():465-488. PubMed ID: 36642250
[TBL] [Abstract][Full Text] [Related]
9. Ocular Drug Delivery: Present Innovations and Future Challenges.
Gote V; Sikder S; Sicotte J; Pal D
J Pharmacol Exp Ther; 2019 Sep; 370(3):602-624. PubMed ID: 31072813
[TBL] [Abstract][Full Text] [Related]
10. Novel Nanomicellar Formulation Approaches for Anterior and Posterior Segment Ocular Drug Delivery.
Cholkar K; Patel A; Vadlapudi AD; Mitra AK
Recent Pat Nanomed; 2012; 2(2):82-95. PubMed ID: 25400717
[TBL] [Abstract][Full Text] [Related]
11. Nanotechnology-based formulations to amplify intraocular bioavailability.
Kagkelaris K; Panayiotakopoulos G; Georgakopoulos CD
Ther Adv Ophthalmol; 2022; 14():25158414221112356. PubMed ID: 35873277
[TBL] [Abstract][Full Text] [Related]
12. Nanotechnology for Topical Drug Delivery to the Anterior Segment of the Eye.
Vaneev A; Tikhomirova V; Chesnokova N; Popova E; Beznos O; Kost O; Klyachko N
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830247
[TBL] [Abstract][Full Text] [Related]
13. A grafted copolymer-based nanomicelles for topical ocular delivery of everolimus: Formulation, characterization, ex-vivo permeation, in-vitro ocular toxicity, and stability study.
Mehra N; Aqil M; Sultana Y
Eur J Pharm Sci; 2021 Apr; 159():105735. PubMed ID: 33516808
[TBL] [Abstract][Full Text] [Related]
14. Ocular Drug Delivery.
Yavuz B; Kompella UB
Handb Exp Pharmacol; 2017; 242():57-93. PubMed ID: 27783270
[TBL] [Abstract][Full Text] [Related]
15. Delivery of therapeutics for deep-seated ocular conditions - status quo.
Nguyen H; Eng S; Ngo T; Dass CR
J Pharm Pharmacol; 2018 Aug; 70(8):994-1001. PubMed ID: 29675844
[TBL] [Abstract][Full Text] [Related]
16. A review of nanocarrier-mediated drug delivery systems for posterior segment eye disease: challenges analysis and recent advances.
Wang R; Gao Y; Liu A; Zhai G
J Drug Target; 2021 Aug; 29(7):687-702. PubMed ID: 33474998
[TBL] [Abstract][Full Text] [Related]
17. Topical ocular drug delivery systems: Innovations for an unmet need.
Yang Y; Lockwood A
Exp Eye Res; 2022 May; 218():109006. PubMed ID: 35248559
[TBL] [Abstract][Full Text] [Related]
18. Nanoparticles in the ocular drug delivery.
Zhou HY; Hao JL; Wang S; Zheng Y; Zhang WS
Int J Ophthalmol; 2013; 6(3):390-6. PubMed ID: 23826539
[TBL] [Abstract][Full Text] [Related]
19. Prodrugs and nanomicelles to overcome ocular barriers for drug penetration.
Gote V; Ansong M; Pal D
Expert Opin Drug Metab Toxicol; 2020 Oct; 16(10):885-906. PubMed ID: 32729364
[TBL] [Abstract][Full Text] [Related]
20. Principles of pharmacology in the eye.
Awwad S; Mohamed Ahmed AHA; Sharma G; Heng JS; Khaw PT; Brocchini S; Lockwood A
Br J Pharmacol; 2017 Dec; 174(23):4205-4223. PubMed ID: 28865239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
